Last update 08 Mar 2025
AndroScience Corp.

AndroScience Corp.

Holding Company|
1999|
California, United States
|
www.androscience.com

Overview

Tags

Neoplasms
Urogenital Diseases
Nervous System Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms4
Nervous System Diseases1
Hemic and Lymphatic Diseases1
Top 5 Drug TypeCount
Small molecule drug5
Unknown1
Top 5 TargetCount
AR(Androgen Receptor)4
STAT3 x STAT5A2

Related

6
Drugs associated with AndroScience Corp.
ASC-JM.X2
Target
AR
Mechanism
AR antagonists
Active Org.
AndroScience Corp.AndroScience Corp.
Originator Org.
AndroScience Corp.AndroScience Corp.
Active Indication
Prostatic Hyperplasia
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
ASC-ST.Z1
Target
STAT3 x STAT5A
Mechanism
STAT3 inhibitors [+1]
Active Org.
AndroScience Corp.AndroScience Corp.
Originator Org.
AndroScience Corp.AndroScience Corp.
Active Indication
Solid tumor
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
ASC-ST.X1
Target
STAT3 x STAT5A
Mechanism
STAT3 inhibitors [+1]
Active Org.
AndroScience Corp.AndroScience Corp.
Originator Org.
AndroScience Corp.AndroScience Corp.
Active Indication
Hematologic Neoplasms
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with AndroScience Corp.
NCT01289574
/ CompletedPhase 2
Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled Clinical Study to Evaluate the Safety and Efficacy of 0.1% and 0.025% ASC-J9 Creams Applied Topically Twice Daily for 12 Weeks for the Treatment of Facial Acne Vulgaris
NCT00525499
/ CompletedPhase 2
A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled Dose-Ranging Clinical Study to Evaluate the Safety and Efficacy of ASC-J9 Cream Applied Twice Daily for 12 Weeks for the Treatment of Facial Acne Vulgaris
100 Clinical Results associated with AndroScience Corp.
Login to view more data
0 Patents (Medical) associated with AndroScience Corp.
Login to view more data
100 Deals associated with AndroScience Corp.
Login to view more data
100 Translational Medicine associated with AndroScience Corp.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 30 Apr 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
6
2
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
ASC-JM.Z1
 ( AR )		Liver Cancer
More
Preclinical
ASC-J9/ASC-JM.X1
 ( AR )		Bulbo-Spinal Atrophy, X-Linked
More
Preclinical
ASC-JM.X2
 ( AR )		Prostatic Hyperplasia
More
Preclinical
ASC-JMX2
 ( AR )		Prostatic Cancer
More
Preclinical
ASC-ST.X1
 ( STAT3 x STAT5A )		Hematologic Neoplasms
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free